Page last updated: 2024-10-25

eflornithine and Hypertrophy, Right Ventricular

eflornithine has been researched along with Hypertrophy, Right Ventricular in 1 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Friberg, P1
Isgaard, J1
Wåhlander, A1
Wickman, A1
Adams, MA1

Other Studies

1 other study available for eflornithine and Hypertrophy, Right Ventricular

ArticleYear
Inhibited expression of insulin-like growth factor I mRNA and attenuated cardiac hypertrophy in volume overloaded hearts treated with difluoromethylornithine.
    Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 1998, Volume: 8, Issue:2

    Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Disease Models, Animal; Eflornithine; Gene Exp

1998